Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Karl Spector

Internal Medicine Bel Air, MD Medical Doctor

NPI 1164472551 CMS profile 324619

602 S Atwood Rd, Unit 200A, Bel Air, MD 21014

Open in the dashboard

General payments

$3,601

206 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Karl Spector of Bel Air, MD is reported in the CMS Open Payments database as having received $3,601 across 206 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,063 54
2024 General $1,002 56
2023 General $718 41
2022 General $148 8
2021 General $95 6
2020 General $138 9
2019 General $437 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Karl Spector
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Karl Spector were reported at $1,063. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Karl Spector Internal Medicine median Middle half National median
2019 $437 $159 $48–$570 $163
2020 $138 $119 $33–$402 $114
2021 $95 $135 $37–$521 $132
2022 $148 $141 $42–$496 $149
2023 $718 $149 $45–$519 $160
2024 $1,002 $154 $47–$537 $164
2025 $1,063 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Novo Nordisk Inc $699 46 payments
  2. Lilly USA, LLC $444 23 payments
  3. AstraZeneca Pharmaceuticals LP $385 21 payments
  4. AbbVie, Inc. $309 18 payments
  5. Pfizer Inc. $299 16 payments
  6. Amgen Inc. $285 17 payments
  7. Abbott Laboratories $170 8 payments
  8. Exact Sciences Corporation $131 8 payments
  9. Almatica Pharma LLC $94 4 payments
  10. Boehringer Ingelheim Pharmaceuticals, Inc. $89 5 payments
  11. Other $695 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,589 205 payments
  2. Education $12 1 payment
Products named General payments · program years 2019–2025
  1. Ozempic $531 35 payments
  2. RYBELSUS $430 27 payments
  3. MOUNJARO $317 15 payments
  4. Prolia $217 13 payments
  5. BREZTRI $198 10 payments
  6. UBRELVY $195 11 payments
  7. EVENITY $172 11 payments
  8. FreeStyle Libre 3 $151 7 payments
  9. ZEPBOUND $144 8 payments
  10. QULIPTA $135 8 payments
  11. Other $2,404 141 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 155 drugs

Part D claims

9,138

Median for Internal Medicine: 777

Drug cost

$751,165

Median for Internal Medicine: $73,373

Branded share of claims

21.8%

Median for Internal Medicine: 19.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 106 $119,028
Trulicity Dulaglutide Brand 49 $101,860
Ozempic Semaglutide Brand 58 $73,853
Xarelto Rivaroxaban Brand 34 $44,277
Jardiance Empagliflozin Brand 22 $34,197
Rybelsus Semaglutide Brand 13 $30,588
Farxiga Dapagliflozin Propanediol Brand 19 $30,440
Xigduo Xr Dapaglifloz Propaned/Metformin Brand 19 $23,838
Nucynta Tapentadol Hcl Brand 12 $23,080
Januvia Sitagliptin Phosphate Brand 12 $19,917

The 10 drugs with the highest cost, of 155 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$179,081

Medicare's payments for the services billed

Medicare patients

892

Average age 76

Services billed

2,279

470 women, 422 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 41%
Diabetes 27%
Ischemic heart disease 27%
Chronic kidney disease 26%
Depression 20%
Atrial fibrillation 18%
COPD 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 28 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BREZTRI
  • AstraZeneca Pharmaceuticals LP $140
$140 — —
RYBELSUS
  • Novo Nordisk Inc $79
$79 13 —
Ozempic
  • Novo Nordisk Inc $79
$79 58 —
MOUNJARO
  • Lilly USA, LLC $75
$75 14 —
NURTEC ODT
  • PFIZER INC. $75
$75 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 28 with Patron

Records

206 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record